Bilateral Cataract after Taking Oxcarbazepine
10.3341/jkos.2019.60.5.486
- Author:
Hyo Jeong KIM
1
;
Na Yeon JUNG
;
Chan Min YANG
;
Tae Young CHUNG
;
Dong Hui LIM
Author Information
1. Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. ldhlse@gmail.com
- Publication Type:Case Report
- Keywords:
Anti epileptic drugs;
Oxcarbazepine;
Subcapsular cataract
- MeSH:
Cataract;
Epilepsy;
Female;
Follow-Up Studies;
Humans;
Mothers;
Risk Factors;
Visual Acuity;
Young Adult
- From:Journal of the Korean Ophthalmological Society
2019;60(5):486-490
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To report a case of bilateral posterior subcapsular cataract after taking oxcarbazepine (Trileptal®, Novartis, Basel, Swiss). CASE SUMMARY: A 19-year-old female visited our clinic with decreased vision in both eyes. Her best-corrected visual acuity was 0.3 in the right eye and 0.5 in the left eye, and slit-lamp examination revealed a bilateral cortical opacity and subcapsular cataract. She had been taking oxcarbazepine for epilepsy for 10 years, which was discontinued 3 years ago. Her mother had undergone cataract surgeries when she was approximately 46 years of age. No other risk factors for cataract were present. CONCLUSIONS: In the present case, bilateral cortical opacity and subcapsular cataract were assumed to be associated with the use of oxcarbazepine. We suggest that oxcarbazepine could induce a cataract and recommend a regular follow-up by a qualified ophthalmologist.
